Medspa Staffing & Salary Guide: RN Injector, NP, Aesthetician

Registered nurses performing injectables (Botox, fillers, biostimulators) typically earn $55,000–$75,000 base salary in mid-market metros (Austin, Nashville, Denver), with top-tier coastal markets (NYC, LA, Miami, San Francisco) commanding $70,000–$95,000. Production bonuses—usually 10–20% of gross revenue from injections they perform—can add $15,000–$40,000 annually depending on patient volume and average transaction value. RNs require state licensure and, in most states, physician supervision for injectables; some states permit independent practice under collaborative agreements. The salary floor has risen 8–12% since 2023, driven by tightening RN supply in aesthetics (many prefer hospital or surgical settings) and practices competing for experienced injectors who can manage their own patient flow. Signing bonuses ($3,000–$8,000) are now common in competitive markets. Practices that offer continuing-education allowances, conference attendance, or certification pathways (e.g., dermatology nursing credentials) see better retention.

NPs command $70,000–$95,000 base in secondary markets, $90,000–$130,000+ in major metros, reflecting their prescribing authority and ability to supervise other clinical staff. Many practices structure NP compensation as a hybrid: base salary plus percentage of gross revenue (8–15%) or per-unit bonuses on toxin and filler sales. An NP generating $400,000–$600,000 in annual procedure revenue can realistically earn $120,000–$160,000 total compensation. State scope-of-practice varies significantly: some states require physician collaboration for all prescribing; others permit independent practice. NPs are increasingly recruited by MSOs and PE-backed roll-ups, which has elevated market rates. Practices offering loan-repayment assistance, flexible scheduling, or a path to part-ownership see competitive advantage. The NP shortage in aesthetics remains acute; many practices struggle to fill these roles and are willing to negotiate equity stakes or profit-sharing for committed candidates.

Licensed aestheticians (non-injectable) earn $35,000–$50,000 base in secondary markets, $45,000–$65,000 in major metros. Commission or bonus structures (5–12% of skincare/device revenue they perform) can add $8,000–$20,000 annually. Aestheticians operate with minimal supervision in most states and can independently perform laser, RF microneedling, chemical peels, and skincare consultations. Their compensation is often lower than injectors because procedure margins are thinner (device depreciation, energy costs, longer treatment times) and patient acquisition is more marketing-dependent. However, aestheticians who build strong skincare-protocol expertise and can upsell maintenance packages command premium pay. Practices investing in advanced training (e.g., certification in RF microneedling depth, laser physics) and offering clear advancement to lead-aesthetician or clinical-coordinator roles see better retention and lower turnover (which averages 25–35% annually in this role).

Coastal Tier-1 markets (NYC, LA, Miami, San Francisco, Boston) command 20–35% salary premiums over secondary markets (Austin, Nashville, Denver, Phoenix, Charlotte). Midwest and rural practices pay 10–20% below secondary-market rates but often offset with lower cost of living and stronger community loyalty. Remote or hybrid arrangements are rare in aesthetics (patient-facing work), but flexible scheduling and shift choice are increasingly expected. Practices in high-rent urban areas often see higher staff turnover due to cost-of-living pressure; offering parking, transit subsidies, or wellness benefits can materially improve retention. The labor market for RN injectors and NPs remains tight: national RN unemployment is near historic lows, and aesthetics competes with hospital systems, surgery centers, and urgent care for the same talent pool. Practices in secondary markets often have recruitment advantage due to lower living costs and less competition from large health systems.

Allergan Aesthetics (Botox, Juvéderm) Alle and Aspire programs, Galderma's Evolus Rewards, and other manufacturer loyalty schemes create tiered rebates based on volume. A practice hitting $500,000+ annual toxin volume can unlock 10–15% rebates, which many owners use to fund staff bonuses or raises without raising patient pricing. Practices that share rebate upside with injectors (e.g., 50% of rebate dollars earned) create a powerful retention tool and align staff incentives with volume growth. This is especially valuable for RN and NP compensation: a $50,000 annual rebate pool can fund $5,000–$10,000 per clinician in discretionary bonuses. Practices not actively managing loyalty-program enrollment and tracking are leaving 5–8% of gross revenue on the table—money that could fund higher salaries or better benefits.

Beyond base salary, competitive practices now offer health insurance (often 80–90% employer-paid), 401(k) matching (3–6%), continuing-education budgets ($1,500–$3,000/year), and professional-liability coverage. Equity or profit-sharing arrangements—once rare in independent practices—are becoming more common as a retention tool for NPs and senior RNs. A 1–5% equity stake or annual profit-sharing bonus can be worth $10,000–$50,000+ depending on practice profitability and growth. Practices with clear advancement pathways (aesthetician → senior aesthetician → clinical coordinator → potential ownership) and transparent financial metrics (patient acquisition cost, average transaction value, staff productivity) report 30–40% lower turnover than those without. Remote onboarding, mentorship programs, and peer learning (e.g., monthly injection-technique reviews) are increasingly expected by younger staff. Practices that invest in staff development and create a clinical culture—not just a revenue machine—attract and retain higher-caliber talent.